Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preliminary results of two dose-finding studies of paclitaxel (Taxol) and carboplatin in non-small cell lung and ovarian cancers: a European Cancer Centre effort.
Giaccone G, Huizing M, ten Bokkel Huinink W, Koolen M, Postmus P, van Kralingen K, van Zandwijk N, Vermorken J, Beijnen J, Dalesio O, et al. Giaccone G, et al. Among authors: van kralingen k, van zandwijk n. Semin Oncol. 1994 Oct;21(5 Suppl 8):34-8. Semin Oncol. 1994. PMID: 7939761 Clinical Trial.
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.
Huizing MT, Giaccone G, van Warmerdam LJ, Rosing H, Bakker PJ, Vermorken JB, Postmus PE, van Zandwijk N, Koolen MG, ten Bokkel Huinink WW, van der Vijgh WJ, Bierhorst FJ, Lai A, Dalesio O, Pinedo HM, Veenhof CH, Beijnen JH. Huizing MT, et al. Among authors: van der vijgh wj, van warmerdam lj, van zandwijk n. J Clin Oncol. 1997 Jan;15(1):317-29. doi: 10.1200/JCO.1997.15.1.317. J Clin Oncol. 1997. PMID: 8996159 Clinical Trial.
Clinical pharmacology of carboplatin administered in combination with paclitaxel.
van Warmerdam LJ, Huizing MT, Giaccone G, Postmus PE, ten Bokkel Huinink WW, van Zandwijk N, Koolen MG, Helmerhorst TJ, van der Vijgh WJ, Veenhof CH, Beijnen JH. van Warmerdam LJ, et al. Among authors: van der vijgh wj, van zandwijk n. Semin Oncol. 1997 Feb;24(1 Suppl 2):S2-97-S2-104. Semin Oncol. 1997. PMID: 9045347 Clinical Trial.
Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer. The EORTC Lung Cancer Cooperative Group. The European Organization for Research and Treatment of Cancer.
Giaccone G, Postmus PE, Splinter TA, Diaz-Puente M, Van Zandwijk N, Scagliotti G, Ardizzoni A, Van Meerbeeck J, Debruyne C. Giaccone G, et al. Among authors: van meerbeeck j, van zandwijk n. Oncology (Williston Park). 1997 Apr;11(4 Suppl 3):11-4. Oncology (Williston Park). 1997. PMID: 9144684 Clinical Trial.
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group.
van Zandwijk N, Groen HJ, Postmus PE, Burghouts JT, ten Velde GP, Ardizzoni A, Smith IE, Baas P, Sahmoud T, Kirkpatrick A, Dalesio O, Giaccone G. van Zandwijk N, et al. Eur J Cancer. 1997 Oct;33(11):1759-66. doi: 10.1016/s0959-8049(97)00174-3. Eur J Cancer. 1997. PMID: 9470829 Clinical Trial.
277 results